Physiomics (LON:PYC) Shares Down 2.8% – Here’s Why

Physiomics Plc (LON:PYC)’s stock price traded down 2.8% during mid-day trading on Wednesday . The company traded as low as GBX 0.33 and last traded at GBX 0.39. 42,169,820 shares changed hands during trading, an increase of 464% from the average session volume of 7,479,108 shares. The stock had previously closed at GBX 0.40.

Physiomics Trading Up 22.0%

The firm’s fifty day moving average is GBX 0.41 and its 200 day moving average is GBX 0.40. The company has a market cap of £1.48 million, a PE ratio of -3.25 and a beta of 1.01.

Physiomics (LON:PYC) last posted its quarterly earnings data on Monday, February 16th. The company reported GBX (0.10) earnings per share for the quarter. Physiomics had a negative return on equity of 89.43% and a negative net margin of 50.92%. As a group, sell-side analysts anticipate that Physiomics Plc will post -0.13 EPS for the current fiscal year.

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.